AD04-13 Study Highlights Consistent Bioavailability and Safety for Alcohol Use Disorder Treatment

admin January 20, 2025 No Comments

Cary Claiborne, CEO, Adial Pharmaceuticals, discusses promising results of the AD04-13 study in patients with Alcohol Use Disorder

Medicine